Sulforaphane supplement to protect the heart during doxorubicin
Part of Heart & circulation, Injuries & trauma clinical trials.
This trial tests whether a nutritional supplement called sulforaphane (SFN) can help protect heart function in people with breast cancer who are receiving doxorubicin (a chemotherapy that can affect the heart). Participants take caplets and have heart and safety monitoring to see if the supplement reduces heart-related side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 89
- Have breast cancer that will be treated with a doxorubicin-containing chemotherapy plan
- Be able to take the study caplets (up to 8 per day)
- If you can become pregnant (typically ages 18–50), agree to use birth control during the study
- You should not have had coronary, carotid, or peripheral artery disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking rosuvastatin (a cholesterol-lowering pill) can help prevent heart damage from anthracycline chemotherapy in women with breast cancer. If you are about to start this type of chemo and have not used statins before, you may qualify.
This trial tests if taking melatonin or vitamin D can help protect the heart in women receiving doxorubicin chemotherapy for breast cancer. It aims to find a safe way to reduce heart damage from treatment.
This trial tests whether a daily pill called dapagliflozin can help protect the heart from damage caused by doxorubicin chemotherapy in people being treated for early-stage breast cancer. If you are starting doxorubicin and have a healthy heart, this might lower your risk of heart problems later.
This trial tests if a medicine called pentoxifylline can help prevent heart damage caused by doxorubicin, a common chemotherapy drug for breast cancer. If you are starting doxorubicin for the first time, this study may offer added heart protection.
This trial tests whether a specific nutrition supplement (amino acids and flavonoids) can lessen chemotherapy side effects, support nutrition, and improve quality of life in people with non-metastatic breast cancer. It focuses on women who are receiving certain chemotherapy medicines and can eat by mouth and attend regular visits.
This trial tests whether grape polyphenols can help protect the heart in women being treated for breast cancer with certain chemotherapy drugs that can harm the heart. If you are at high risk for heart problems from chemo, this study may offer a way to reduce that risk.
Hear when a new Anthracycline Related Cardiotoxicity in Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.